Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mechanisms associated with chemoresistance in esophageal cancer
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

Epithelioids: Self-sustaining 3D epithelial cultures to study long-term processes
Albert Herms, David Fernández‐Antorán, Maria P. Alcolea, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Exosomal circular RNAs: A key player in cancer drug resistance
Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, et al.
Gene Reports (2023) Vol. 33, pp. 101835-101835
Closed Access | Times Cited: 2
CNTN-1 Upregulation Induced by Low-Dose Cisplatin Promotes Malignant Progression of Lung Adenocarcinoma Cells via Activation of Epithelial-Mesenchymal Transition
Ruijie Zhang, Shengjin Li, Jian Lan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
WITHDRAWN: Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies

Research Square (Research Square) (2024)
Open Access
Nanoparticle delivery of si-Notch1 modulates metabolic reprogramming to affect 5-FU resistance and cell pyroptosis in colorectal cancer
Dandan Li, Jiacheng Jin, Xuan-wen Liu, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access
Circrna Expression Profiles and The Role of HDAC9 in Cisplatin Resistance of Esophageal Squamous Cell Carcinoma

Journal of Surgery (2024) Vol. 9, Iss. 5
Open Access
ANP32E promotes esophageal cancer progression and paclitaxel resistance via P53/SLC7A11 axis-regulated ferroptosis
Li‐Ying Sun, Shaobo Ke, Boxin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113436-113436
Closed Access
Exosomal miR-130a-3p confers cisplatin resistance in esophageal cancer by regulating ferroptosis via the suppression of METTL14-mediated m6A RNA methylation of FSP1
Hu Han, Yan Li, Zhiyi Lin, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113804-113804
Closed Access
Clinical Significance and Prognostic Value of the Expression of LAG-3 and FGL1 in Esophageal Squamous Cell Carcinoma
Xiaofeng Yao, F. H. Zhang, Ying Liu
Bulletin of Experimental Biology and Medicine (2023) Vol. 174, Iss. 6, pp. 774-778
Closed Access | Times Cited: 1
Resveratrol reverses drug resistance of esophageal cancer cell line Eca109/DDP via regulating ferroptosis
Chen-Deng Wang, Bai-Qiang Ma, Bi-Shun Yi
Shijie huaren xiaohua zazhi (2023) Vol. 31, Iss. 12, pp. 477-484
Open Access
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies
Andrei L. Gartel, Sanjeev Raghuwanshi, Xu Zhang, et al.
Research Square (Research Square) (2023)
Open Access
Previous Page - Page 2

Scroll to top